Pharmaceutical Executive April 19, 2024
Chris Martin

Insight that can help smaller biotech companies prepare for commercialization in the world of big pharma.

Thomas Edison once said, “Good fortune is what happens when opportunity meets with planning.” As the American inventor of the light bulb and the first recording device, it seems like advice worth heeding.

In today’s world of drug development—in which a most promising treatment can fail or underperform its market potential because an optimal commercialization plan is not implemented—there is a lot to consider when bringing together opportunity and planning to deliver a drug to market. It can be both an art and a science.

The road to commercialization is long and challenging. I’ve launched products in several disease states from companies both large...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Project Optimus: helping or hindering cancer drug development?
Faster Drug Discovery: Yseop & AWS Unveils GenAI Tool for Biopharma R&D
Quest to ramp up AI capabilities with purchase of PathAI’s diagnostic lab
Karius Secures $100M to Expand Non-Invasive Pathogen Blood Test
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold

Share This Article